Google Life Sciences and the American Heart Association team up on new research venture

Google Life Sciences (GLS) and the American Heart Association (AHA) has announced a $50 million collaboration to find new ways to fight heart disease.

GLS  and AHA have agreed to invest $25 million each for a total of $50 million over roughly five years to fund research in coronary heart disease, which causes one in every three deaths in the United States.

Heart disease is the world's top killer, a problem that "seems ripe for new innovation" and disruptive, unconventional thinking, said Andy Conrad, Google Life Sciences' chief executive. Progress has been slow and "we should shake it up a little bit," he said.

What is surprising about the collaboration is how the money will be distributed: all $50 million will go to one interdisciplinary team led by one investigator.

This marks the largest one-time research investment in AHA’s history. For the Google group, its latest biomedical venture will join projects that include innovative devices such as driverless cars, contact lenses that monitor blood-sugar for diabetics and health-tracking wristbands.

The official announcement can be found here.


Date: 07/12/2015 | Tag: | News: 434 of 826
All news

News

More news

Events

More events
newsletter

Subscribe to the VPH Institute Newsletter

Accept Privacy Policy

ARCHIVE

Read all the newsletters of the VPH Institute

GO